There are molecules being developed that will have profound impacts on the lives of millions of patients across the globe, but many of these miraculous discoveries will never make it to market because pharma companies don’t have a clear line of sight through the drug development life cycle. They need data and insights to prioritize their portfolios and make better decisions about where to invest their resources more efficiently. They need a new way to identify the therapies that have the greatest potential to succeed.

By integrating real-world data, predictive analytics, and patient-centric models, Norstella improves the success rates of clinical trials; finds patients and coverage paths that no one else can; and fosters a more effective and economically sound health system. Therapies are getting to the people who need them sooner because we’re helping pharma companies make more meaningful decisions. Access to better data, better insights, and better decision-making earlier in the development life cycle is transformative for the industry — and people’s lives.